Literature DB >> 18612141

Tissue inhibitors of metalloproteinases in cell signaling: metalloproteinase-independent biological activities.

William G Stetler-Stevenson1.   

Abstract

Over the past 20 years, the tissue inhibitors of metalloproteinases (TIMPs) have been implicated in direct regulation of cell growth and apoptosis. However, the mechanisms of these effects have been controversial. Recent work by several laboratories has identified specific signaling pathways and cell surface binding partners for members of the TIMP family. TIMP-2 binding to the integrin alpha(3)beta(1) is the first description of a cell surface receptor for a TIMP family member. TIMP-2 has been shown to induce gene expression, to promote G(1) cell cycle arrest, and to inhibit cell migration. TIMP-1 binding to CD63 inhibits cell growth and apoptosis. These new findings suggest that TIMPs are multifunctional and can act either directly through cell surface receptors or indirectly through modulation of protease activity to direct cell fate. The emerging concept is that TIMPs function in a contextual fashion so that the mechanism of action depends on the tissue microenvironment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18612141      PMCID: PMC2493614          DOI: 10.1126/scisignal.127re6

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  107 in total

1.  Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.

Authors:  Ki-Kyung Jung; Xu-Wen Liu; Rosemarie Chirco; Rafael Fridman; Hyeong-Reh Choi Kim
Journal:  EMBO J       Date:  2006-08-17       Impact factor: 11.598

2.  Tissue inhibitor of metalloproteinases 1 regulation of interleukin-10 in B-cell differentiation and lymphomagenesis.

Authors:  L Guedez; A Mansoor; B Birkedal-Hansen; M S Lim; P Fukushima; D Venzon; W G Stetler-Stevenson; M Stetler-Stevenson
Journal:  Blood       Date:  2001-03-15       Impact factor: 22.113

3.  Invertebrate tissue inhibitor of metalloproteinase: structure and nested gene organization within the synapsin locus is conserved from Drosophila to human.

Authors:  N Pohar; T A Godenschwege; E Buchner
Journal:  Genomics       Date:  1999-04-15       Impact factor: 5.736

4.  Tissue inhibitor of metalloproteinases-2 (TIMP-2) suppresses TKR-growth factor signaling independent of metalloproteinase inhibition.

Authors:  S E Hoegy; H R Oh; M L Corcoran; W G Stetler-Stevenson
Journal:  J Biol Chem       Date:  2000-10-19       Impact factor: 5.157

5.  TIMP-1 regulation of cell cycle in human breast epithelial cells via stabilization of p27(KIP1) protein.

Authors:  M E Taube; X-W Liu; R Fridman; H-R C Kim
Journal:  Oncogene       Date:  2006-05-18       Impact factor: 9.867

6.  The expression of tissue inhibitor of metalloproteinase 2 (TIMP-2) is required for normal development of zebrafish embryos.

Authors:  Jinsong Zhang; Shan Bai; Carmen Tanase; Hideaki Nagase; Michael P Sarras
Journal:  Dev Genes Evol       Date:  2003-05-08       Impact factor: 0.900

7.  Three-dimensional structure of human tissue inhibitor of metalloproteinases-2 at 2.1 A resolution.

Authors:  A Tuuttila; E Morgunova; U Bergmann; Y Lindqvist; K Maskos; C Fernandez-Catalan; W Bode; K Tryggvason; G Schneider
Journal:  J Mol Biol       Date:  1998-12-11       Impact factor: 5.469

8.  TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3.

Authors:  A Amour; P M Slocombe; A Webster; M Butler; C G Knight; B J Smith; P E Stephens; C Shelley; M Hutton; V Knäuper; A J Docherty; G Murphy
Journal:  FEBS Lett       Date:  1998-09-11       Impact factor: 4.124

9.  Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor.

Authors:  Cecilia A Fernández; Catherine Butterfield; Geraldine Jackson; Marsha A Moses
Journal:  J Biol Chem       Date:  2003-08-04       Impact factor: 5.157

10.  Tissue inhibitor of metalloproteinases-1 promotes liver metastasis by induction of hepatocyte growth factor signaling.

Authors:  Charlotte Kopitz; Michael Gerg; Obul Reddy Bandapalli; Dilek Ister; Caroline J Pennington; Stephanie Hauser; Christin Flechsig; Hans-Willi Krell; Dalibor Antolovic; Keith Brew; Hideaki Nagase; Manfred Stangl; Claus W Hann von Weyhern; Björn L D M Brücher; Karsten Brand; Lisa M Coussens; Dylan R Edwards; Achim Krüger
Journal:  Cancer Res       Date:  2007-09-15       Impact factor: 12.701

View more
  189 in total

1.  Comparison of metalloproteinase protein and activity profiling.

Authors:  Orsi Giricz; Janelle L Lauer; Gregg B Fields
Journal:  Anal Biochem       Date:  2010-10-23       Impact factor: 3.365

2.  Remodeling in vein expresses arterial phenotype in hyperhomocysteinemia.

Authors:  Poulami Basu; Natia Qipshidze; Suresh C Tyagi; Utpal Sen
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-15

3.  Use of gel zymography to examine matrix metalloproteinase (gelatinase) expression in brain tissue or in primary glial cultures.

Authors:  Harald Frankowski; Yu-Huan Gu; Ji Hoe Heo; Richard Milner; Gregory J Del Zoppo
Journal:  Methods Mol Biol       Date:  2012

4.  Endogenous angiogenesis inhibitor blocks tumor growth via direct and indirect effects on tumor microenvironment.

Authors:  Dimitra Bourboulia; Sandra Jensen-Taubman; Matthew R Rittler; Hui Ying Han; Tania Chatterjee; Beiyang Wei; William G Stetler-Stevenson
Journal:  Am J Pathol       Date:  2011-09-18       Impact factor: 4.307

5.  TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury.

Authors:  Sergio Duarte; Takashi Hamada; Naohisa Kuriyama; Ronald W Busuttil; Ana J Coito
Journal:  Hepatology       Date:  2012-07-11       Impact factor: 17.425

6.  Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells.

Authors:  Karyn G Robinson; Ting Nie; Aaron D Baldwin; Elaine C Yang; Kristi L Kiick; Robert E Akins
Journal:  J Biomed Mater Res A       Date:  2012-02-28       Impact factor: 4.396

Review 7.  Fetal hypoxia and programming of matrix metalloproteinases.

Authors:  Wenni Tong; Lubo Zhang
Journal:  Drug Discov Today       Date:  2011-09-18       Impact factor: 7.851

Review 8.  Control of death receptor ligand activity by posttranslational modifications.

Authors:  R Weinlich; T Brunner; G P Amarante-Mendes
Journal:  Cell Mol Life Sci       Date:  2010-03-20       Impact factor: 9.261

Review 9.  Metzincin proteases and their inhibitors: foes or friends in nervous system physiology?

Authors:  Santiago Rivera; Michel Khrestchatisky; Leszek Kaczmarek; Gary A Rosenberg; Diane M Jaworski
Journal:  J Neurosci       Date:  2010-11-17       Impact factor: 6.167

10.  Matrix metalloproteinase-9-mediated tissue injury overrides the protective effect of matrix metalloproteinase-2 during colitis.

Authors:  Pallavi Garg; Matam Vijay-Kumar; Lixin Wang; Andrew T Gewirtz; Didier Merlin; Shanthi V Sitaraman
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-02       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.